ARCHIVES

Cancer Advocates Ask House By Byspass Budget; NCCR’s Day Calls For $380 Mil. Minimum Increase

This article is from The Cancer Letter archive.

Vol. 19 No. 11 | March 12, 1993

Download PDF Visit The Full Archive

Related Articles

Risk Assessment Key In Long-Term Treatment

August 29, 2008

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996

In This Issue: The controversy Over “Cancer Undefeated”

June 6, 1997

NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ

October 24, 1997

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993